As per the latest report by IMARC Group, titled “Breast Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global breast imaging market reached a value of US$ 4.2 Billion in 2022. Breast imaging refers to the technique of diagnosing breast cancer through high-resolution images of breast tissues in both males and females. It involves numerous ionizing and non-ionizing technologies to screen, detect, and diagnose the type of cancer, its location, and stage of progression. It also utilizes various imaging procedures, such as screening mammography and breast ultrasound, to check for suspicious tissues and the surrounding auxiliary tissues for the early diagnosis of cancer before the actual symptoms appear.
Global Breast Imaging Market Trends:
The growing incidences of breast cancer are primarily driving the global breast imaging market. Besides this, the increasing awareness regarding the early detection of breast cancer and related diseases is also contributing to the market growth. Furthermore, the World Health Organization (WHO) has identified breast cancer as one of the most prevalent forms of cancer among women. As a result, governments worldwide are taking initiatives and preventive measures to mitigate the risk factors and enhance cancer screening and diagnosis. For instance, the Government of the United Kingdom has launched the “Be clear on cancer” program, which focuses on the early diagnosis of cancer. This has led to a significant rise in the adoption rate of breast imaging procedures across the globe. Moreover, extensive investments in advanced imaging software and hybrid systems, such as automated whole breast ultrasound systems (AWBU) and MBI/BSGI, are also facilitating market growth. On account of these factors, the market value is expected to reach US$ 6.8 Billion by 2028, exhibiting a CAGR of 8.7% during the forecast period (2023-2028).
- Based on technology, the market has been divided into ionizing breast imaging (mammography, positron emission tomography-computed tomography, molecular breast imaging, positron emission mammography, and cone-beam computed tomography), non-ionizing breast imaging (breast ultrasound, breast MRI, automated whole-breast ultrasound, breast thermography, electric impedance tomography and optical imaging).
- On the basis of the end-user, the market has been classified into hospitals, diagnostic imaging centers, ambulatory surgical centers, and others.
- On the geographical front, major regions include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Allengers Medical Systems Limited, Aurora Health Care Inc. (Schoen Clinic), Canon Inc., Carestream Health Inc. (Onex Corporation), Delphinus Medical Technologies, Dilon Technologies Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Micrima Limited, Planmed Oy, Siemens Healthineers AG (Cerner Corporation) and Toshiba Corporation.
|Base Year of the Analysis
||Technology, End-User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Allengers Medical Systems Limited, Aurora Health Care Inc. (Schoen Clinic), Canon Inc., Carestream Health Inc. (Onex Corporation), Delphinus Medical Technologies, Dilon Technologies Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Micrima Limited, Planmed Oy, Siemens Healthineers AG (Cerner Corporation) and Toshiba Corporation
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800